Carfilzomib in Combination for the Treatment of RR MM

Clinical trial NCT04004338 · UNKNOWN

Trial details

NCT number: NCT04004338
Sponsor: Black Sea Hematology Association
Status: UNKNOWN
Study type: OBSERVATIONAL

Multiple Myeloma Relapse Multiple Myeloma Refractory Multiple Myeloma

Start date: 2019-04-14
Primary completion: 2021-04-14
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.